Helping clinics put proven opioid and pain treatments into practice
HD2A Research Adoption Support Center (RASC)
This center helps healthcare sites use proven treatments for substance use and pain so more people can get care that reduces overdose risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11180154 on NIH RePORTER |
What this research studies
From my point of view, this center teams up with about 10–12 local projects to help clinics and programs adopt evidence-based treatments for opioid use disorder and pain. They have four parts: leadership, implementation support for substance use, implementation support for pain, and a research and evaluation team to track progress. The center will create a catalog of effective practices, offer coaching and training in implementation methods, and build data tools to monitor how well sites put treatments into routine care. Their work focuses on speeding up real-world use of treatments that can prevent overdoses and improve pain management.
Who could benefit from this research
Good fit: People with opioid use disorder, those at risk of overdose, and patients with chronic pain who receive care from participating clinics or programs are the most likely to benefit.
Not a fit: People who are not connected to participating health systems or whose health issues are unrelated to substance use or pain are unlikely to see direct benefits from this center.
Why it matters
Potential benefit: If successful, this effort could get effective treatments to more people faster, potentially lowering overdose deaths and improving pain care.
How similar studies have performed: Smaller implementation initiatives have helped clinics adopt substance-use treatments, but this coordinated national support center approach is newer and aims to scale those improvements.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mcgovern, Mark P — Stanford University
- Study coordinator: Mcgovern, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.